Literature DB >> 2003797

Association of HLA antigens with Vogt-Koyanagi-Harada syndrome in a Han Chinese population.

M Zhao1, Y Jiang, I W Abrahams.   

Abstract

Vogt-Koyanagi-Harada syndrome, or the uveomeningitis syndrome, is one of the most commonly identified types of endogenous uveitis diagnosed in China. Because its incidence is higher in Orientals than in whites, immunogenetic background [corrected] may be an important factor in its incidence. We performed HLA-A, -B, and -DR typing on 25 patients with Vogt-Koyanagi-Harada syndrome and on 65 healthy control subjects from the Han Chinese population. The results showed that HLA-DR4 and -Dw53 were closely associated with Vogt-Koyanagi-Harada syndrome (P less than .001 [relative risk = 16.0] and P less than .001 [relative risk = 34.2], respectively). This association is similar to that reported in patients with Vogt-Koyanagi-Harada syndrome in Japan, suggesting that DR4 and DRw53 may play important roles in the development of Vogt-Koyanagi-Harada syndrome in Oriental populations.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 2003797     DOI: 10.1001/archopht.1991.01080030070041

Source DB:  PubMed          Journal:  Arch Ophthalmol        ISSN: 0003-9950


  17 in total

1.  [Recurrent uveitis with bilateral exudative retinal detachment. 10-year-old boy with bilaterally impaired vision and eye pain. Vogt-Koyanagi-Harada syndrome].

Authors:  E-M Kohnen; Y Pansdorf; A Zubcov
Journal:  Ophthalmologe       Date:  2003-06-07       Impact factor: 1.059

2.  Genome-wide association analysis of Vogt-Koyanagi-Harada syndrome identifies two new susceptibility loci at 1p31.2 and 10q21.3.

Authors:  Shengping Hou; Liping Du; Bo Lei; Chi Pui Pang; Meifen Zhang; Wenjuan Zhuang; Minglian Zhang; Lulin Huang; Bo Gong; Meilin Wang; Qi Zhang; Ke Hu; Qingyun Zhou; Jian Qi; Chaokui Wang; Yuan Tian; Zi Ye; Liang Liang; Hongsong Yu; Hong Li; Yan Zhou; Qingfeng Cao; Yunjia Liu; Lin Bai; Dan Liao; Aize Kijlstra; Jianfeng Xu; Zhenglin Yang; Peizeng Yang
Journal:  Nat Genet       Date:  2014-08-10       Impact factor: 38.330

Review 3.  [Human leukocyte antigen (HLA) system in ophthalmology].

Authors:  T Lapp; D Reinhold; D Böhringer; T Reinhard
Journal:  Ophthalmologe       Date:  2013-09       Impact factor: 1.059

4.  Vogt-Koyanagi-Harada syndrome associated with cutaneous malignant melanoma: an 11-year follow-up.

Authors:  Sabine Aisenbrey; Christoph Lüke; Helen D Ayertey; Salvatore Grisanti; Andreas Perniok; Richard Brunner
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2003-11-14       Impact factor: 3.117

5.  HLA-DRB1 typing of Vogt-Koyanagi-Harada's disease by PCR-RFLP and the strong association with DRB1*0405 and DRB1*0410.

Authors:  Y Shindo; H Inoko; T Yamamoto; S Ohno
Journal:  Br J Ophthalmol       Date:  1994-03       Impact factor: 4.638

6.  Monocyte chemoattractant protein (MCP)-1 -2518 A/G SNP in Chinese Han patients with VKH syndrome.

Authors:  Shengping Hou; Peizeng Yang; Lin Xie; Liping Du; Hongyan Zhou; Zhengxuan Jiang
Journal:  Mol Vis       Date:  2009-08-08       Impact factor: 2.367

7.  PDCD1 genes may protect against extraocular manifestations in Chinese Han patients with Vogt-Koyanagi-Harada syndrome.

Authors:  Qianli Meng; Xiaoli Liu; Peizeng Yang; Shengping Hou; Liping Du; Hongyan Zhou; Aize Kijlstra
Journal:  Mol Vis       Date:  2009-02-20       Impact factor: 2.367

8.  TNFAIP3 gene polymorphisms in a Chinese Han population with Vogt-Koyanagi-Harada syndrome.

Authors:  Hong Li; Qing Liu; Shengping Hou; Liping Du; Qingyun Zhou; Yan Zhou; Aize Kijlstra; Peizeng Yang
Journal:  PLoS One       Date:  2013-03-21       Impact factor: 3.240

9.  Small ubiquitin-like modifier 4 (SUMO4) polymorphisms and Vogt-Koyanagi-Harada (VKH) syndrome in the Chinese Han population.

Authors:  Shengping Hou; Peizeng Yang; Liping Du; Hongyan Zhou; Xiaomin Lin; Xiaoli Liu; Aize Kijlstra
Journal:  Mol Vis       Date:  2008-12-31       Impact factor: 2.367

10.  Polymorphisms of FCRL3 in a Chinese population with Vogt-Koyanagi-Harada (VKH) syndrome.

Authors:  Ke Li; Peizeng Yang; Min Zhao; Shengping Hou; Liping Du; Hongyan Zhou; Aize Kijlstra
Journal:  Mol Vis       Date:  2009-05-11       Impact factor: 2.367

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.